Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.

Abstract: In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.

Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.

Abstract: In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.

Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.

Abstract: The invention provides methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention provides a microarray for obtaining gene expression data from a lymphoma sample. The invention also provides a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma, which is useful in developing an appropriate therapeutic approach.

Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.

Abstract: The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.

Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.

Abstract: The invention provides methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention provides a microarray for obtaining gene expression data from a lymphoma sample. The invention also provides a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma, which is useful in developing an appropriate therapeutic approach.

Abstract: The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information is useful in developing the appropriate therapeutic approach for use with a particular subject.

Abstract: Burial capsule with an internal inert gas atmosphere for use to contain the human corpse, or other valuable items, and to protect such items from decay and/or decomposition for an infinite period of time. The burial capsule comprises a one (1) piece elongated, cylindrically shaped enclosure, accomplished by chemically welding two (2) identically configured, homogeneous plastic parts together along a common interfacing surface area. The enclosure contains a single, minute aperture at each opposing end, into which a compatible plastic material female reducer means is chemically welded. A plastic hose adapter is temporarily installed into each reducer; a remote vacuum pump is attached to one (1) adapter, and a remote inert gas means is temporarily attached to the other adapter. The simultaneous activation of the pump and gas means effectively evacuates essentially all of the contaminated gases, and injects an oxygen free, inert gas, environment directly into the confines of the burial capsule.

Abstract: An optical and electromagnetic system for checking aerosol container closures for split curls, and for the presence of a continuous bead of sealing compound. The compound is applied to a depression about the periphery of inverted closures, and closures conveyed in single file fashion to an inspection station. A light source disposed in a rotating head above the inspection station scans the periphery of each closure, while a sensor rotating with the source responds to interruptions or voids in the compound. An electromagnetic transducer is rotatably mounted beneath the station and simultaneously scans the curl at the bottom of the inverted closure, producing a defect signal if a split curl is detected. A signal processing system prevents the system from reacting to spurious signals caused by the transit of closures past the inspection station.

Abstract: A stream of cylindrical metal containers is fed into apparatus having a rotatable turret. The turret indexes each container past a driven wheel for imparting rotation thereto, and the rotating containers are scanned by a split flange detector. At the same or another point about the turret, a proximity detector disposed in close conjunction with the periphery of the rotating container detects any substantial runout of the periphery, indicating a dented container. Still another inspection station comprises a source of diffuse light directed against the sidewalls within a container, and a photosensor directed toward the container end for registering the intensity of reflected light. The light intensity is used as an indication of the presence (or absence) of coating material on substantial areas of the container interior.